Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Recruiting · NCT07207564 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Non-Interventional Study
What this trial is about
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Who can take part
Age range
18 Years to 100 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Female patients, ages 18 to 100 years
- Had a benign breast biopsy at Mayo Clinic between 2002-2022
Exclusion criteria
- All male patients
- Prior or concomitant diagnosis of BC
- Diagnosis of BC within six months of benign breast disease
- Denial of research authorization
- Concurrent or post-biopsy bilateral prophylactic mastectomy
Where it is running
2 locations listed across 2 US states.
- Mayo Clinic in Florida - Jacksonville, Florida, United States
- Mayo Clinic in Rochester - Rochester, Minnesota, United States